# clm_800F88E2D840

subject: Novo Nordisk (/record/novo-nordisk.md)  
predicate: total_equity  
value: 83,486,000,000 DKK  
valid_from: 2022-12-31  
valid_to: 2023-12-31  
published: 2023-02-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A40D8D2F280A  
last_updated: 2026-11-08  
cite: AsOf. "Novo Nordisk total equity: 83,486,000,000 DKK", as of 2022-12-31 (until 2023-12-31). Claim clm_800F88E2D840, https://asof.is/claim/clm_800F88E2D840, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828023001868/0001628280-23-001868-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: ifrs-full:Equity in 20-F FY2022, filed 2023-02-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/353278/000162828023001868/0001628280-23-001868-index.htm (primary, SEC EDGAR 20-F FY2022, published 2023-02-01)

## Supersedes

- [Novo Nordisk](/record/novo-nordisk.md) | total_equity | 70,746,000,000 DKK | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_800F88E2D840](/claim/clm_800F88E2D840.md) | [clm_1B204B243A08](/claim/clm_1B204B243A08.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.